Baird analyst Jeff Johnson lowered the firm’s price target on Align Technology (ALGN) to $276 from $325 and keeps an Outperform rating on the shares. The firm said the 3Q revenue/case shipments missed Street/guidance and management guided 4Q below. None of that is encouraging and likely sends shares lower.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGN:
- Align Technology sees Q4 revenue $995M-$1.015B, consensus $1.01B
- Align Technology introduces Invisalign Smile Architect
- Align Technology announces iTero intraoral scanner product innovations
- Align Technology reports Q3 adjusted EPS $2.35, consensus $2.31
- Align Technology options imply 10.2% move in share price post-earnings